Chiome Bioscience Inc. (TYO:4583)
142.00
-6.00 (-4.05%)
Jun 6, 2025, 3:30 PM JST
Chiome Bioscience Revenue
Chiome Bioscience had revenue of 138.70M JPY in the quarter ending March 31, 2025, with 6.98% growth. This brings the company's revenue in the last twelve months to 789.86M, up 22.90% year-over-year. In the year 2024, Chiome Bioscience had annual revenue of 780.81M with 14.41% growth.
Revenue (ttm)
789.86M
Revenue Growth
+22.90%
P/S Ratio
12.18
Revenue / Employee
14.90M
Employees
53
Market Cap
9.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 780.81M | 98.35M | 14.41% |
Dec 31, 2023 | 682.46M | 51.65M | 8.19% |
Dec 31, 2022 | 630.82M | -82.12M | -11.52% |
Dec 31, 2021 | 712.93M | 232.08M | 48.26% |
Dec 31, 2020 | 480.85M | 33.28M | 7.43% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Mar 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |